# International Flavors & Fragrances, Inc

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/International Flavors & Fragrances, Inc).

## Overview

International Flavors & Fragrances Inc. develops and manufactures ingredients and compounds used in foods, beverages, health and biosciences products, and scents. Its portfolio spans taste systems, food ingredients, enzymes, cultures, probiotics, and fragrance compounds/ingredients sold to consumer-product and industrial manufacturers worldwide.

## Products & services

• Taste systems for food and beverage formulation
• Food ingredients, including proteins and functional ingredients
• Health & biosciences ingredients such as enzymes, cultures and probiotics
• Fragrance compounds for fine and consumer fragrances
• Fragrance ingredients sold internally and to third parties
• Former Pharma Solutions excipients and nitrocellulose businesses (divested in 2025)

- **Taste** (18%) — Flavor and taste solutions used in dairy, beverages, snacks, savory, sweet and baked goods.
- **Food Ingredients** (24%) — Protein solutions and other functional food ingredients used to improve texture, nutrition and formulation.
- **Health & Biosciences** (20%) — Enzymes, cultures, probiotics and related bioscience ingredients for food, health and industrial uses.
- **Scent** (28%) — Fragrance compounds and fragrance ingredients for fine fragrance, home care and personal care products.
- **Pharma Solutions / divested businesses** (10%) — Pharmaceutical excipients and nitrocellulose businesses that were sold in 2025 and no longer contribute ongoing revenue.

- Taste systems for food and beverage formulation
- Food ingredients, including proteins and functional ingredients
- Health & biosciences ingredients such as enzymes, cultures and probiotics
- Fragrance compounds for fine and consumer fragrances
- Fragrance ingredients sold internally and to third parties
- Former Pharma Solutions excipients and nitrocellulose businesses (divested in 2025)

## Customers

IFF sells primarily to manufacturers of consumer and industrial products, not to end consumers. Core buyers include food, beverage, personal care, home care, fragrance and pharmaceutical customers that need formulation expertise, regulatory support and proprietary ingredients. The company also serves a broad base of small and mid-sized customers, while a smaller group of multinational customers drives a meaningful share of sales and requires inclusion on core supplier lists.

- **Multinational consumer products companies** (primary) — Large global customers buy fragrance, taste and functional ingredients and value supply reliability, innovation and core-list status.
- **Food and beverage manufacturers** (primary) — Dairy, meat, beverage, snack, bakery and savory producers buy taste systems and food ingredients to improve flavor, texture and nutrition.
- **Home and personal care manufacturers** (primary) — Soap, detergent, cleaning and personal care companies buy fragrance compounds and ingredients for product differentiation.
- **Small and mid-sized customers** (secondary) — Regional and niche manufacturers buy customized formulations and technical support; this base is broad but individually smaller.
- **Pharmaceutical and supplement customers** (secondary) — These customers historically bought excipients and related materials from Pharma Solutions, which was divested in 2025.

- Large multinational consumer products companies buying on core supplier lists
- Food and beverage manufacturers needing taste and functional ingredients
- Personal care, soap and detergent makers using scent and formulation inputs
- Fragrance houses and brand owners buying fine fragrance compounds
- Small and mid-sized customers seeking tailored formulations and technical support
- Pharmaceutical and supplement makers that used Pharma Solutions before divestiture

## Geography

IFF is globally diversified, with the United States representing about 28% of 2025 sales and no other country above 10%. The company sources roughly 20,000 raw materials from domestic and international suppliers and holds a majority of cash outside the U.S., which increases foreign exchange and repatriation considerations. Its manufacturing, R&D and creative network is international, so regional demand shifts, trade policy and currency movements can affect both sales and margins.

- **United States** (28%) — Disclosed in 2025 annual report as approximately 28% of sales.
- **Rest of world** (72%) — No other country represented more than 10% of sales.

- United States was about 28% of 2025 sales
- No other single country exceeded 10% of sales
- Global sourcing spans about 20,000 raw materials
- Majority of cash is held outside the United States
- International manufacturing and creative labs support local customer needs

## Strategy

IFF is reshaping its portfolio around higher-priority taste, food ingredients, health & biosciences and scent businesses after divesting Pharma Solutions and other non-core assets. Management is emphasizing customer intimacy, innovation, sustainability-related product attributes and core-supplier positioning to defend share with large multinationals and win new formulations. The company is also using restructuring and portfolio simplification to improve focus after a major segment reorganization and goodwill impairment.

- **Portfolio simplification and core-business focus** (short-term) — Divestitures reduce complexity and allow capital and management attention to shift toward higher-priority categories.
- **Customer intimacy and core-list positioning** (medium-term) — Large customers drive meaningful revenue, so maintaining approved supplier status is critical to growth and margin retention.
- **Innovation in taste, scent and biosciences** (medium-term) — Proprietary formulations and application expertise differentiate the company in competitive ingredient markets.
- **Productivity and supply-chain resilience** (short-term) — A broad raw-material base and global manufacturing footprint require ongoing efficiency and supply security.

- Focus on core taste, food ingredients, health & biosciences and scent
- Use divestitures to simplify the portfolio and sharpen management focus
- Win and retain core supplier status with multinational customers
- Invest in R&D, creative centers and application labs for formulation wins
- Develop sustainability-related and clean-label solutions customers expect
- Improve productivity and supply-chain efficiency across a global network

## Risks

IFF faces demand volatility because its ingredients sit inside consumer products whose volumes depend on end-market trends, retailer dynamics and customer order timing. The business is also exposed to regulatory, quality, antitrust, supply-chain and geopolitical risks, while portfolio changes and goodwill testing can create large non-cash charges. Because the company sells to a concentrated group of large customers but serves a broad base overall, losing core-list status or failing to execute divestitures and restructuring could pressure sales and margins.

- **Customer demand and preference shifts** [high] — IFF's ingredients are embedded in consumer products, so changes in end-market demand flow through to order volumes and product mix.
- **Regulatory and product compliance** [high] — The company operates in heavily regulated categories where safety, labeling and environmental standards can raise costs or restrict sales.
- **Customer concentration and core-list dependence** [high] — A relatively small number of multinational customers account for a meaningful share of revenue and can demand rebates or switch suppliers.
- **Supply-chain and geopolitical disruption** [medium] — The company sources thousands of raw materials globally, making it vulnerable to tariffs, sanctions, logistics issues and natural disasters.
- **Goodwill impairment and portfolio restructuring** [high] — Segment reorganization and changing fair values can produce large impairment charges and signal weaker underlying economics.

- Customer demand can shift quickly with consumer trends and retailer changes
- Large customer concentration creates core-list and pricing pressure risk
- Regulatory, quality and labeling failures can trigger recalls and penalties
- Raw-material, energy, freight and tariff inflation can compress margins
- Supply-chain and geopolitical disruptions can affect sourcing and delivery
- Goodwill and divestiture-related impairment risk remains material

## Accounting

The most important accounting issue is goodwill and reporting-unit valuation, because IFF recorded a $1.153 billion impairment in Food Ingredients after reorganizing segments in 2025. Divestitures also affect comparability and can create gains, losses, held-for-sale accounting and portfolio-mix distortions, while foreign cash balances and tax realignment items add complexity to reported results. Investors should also watch estimates tied to fair value, tax benefits from legal entity realignment, and any provisions or contingencies from litigation and compliance matters.

- **Goodwill impairment** — Large non-cash charge to earnings and equity
- **Divestiture accounting** — Distorts year-over-year growth and segment margins
- **Fair value estimates** — Can materially affect impairment tests and tax outcomes
- **Tax realignment project** — Can create significant one-time tax volatility

- Goodwill impairment can materially reduce earnings and signal weaker fair values
- Segment reorganization changed reporting units and required re-testing goodwill
- Divestitures affect comparability and can create held-for-sale accounting impacts
- Foreign cash balances and repatriation assumptions affect liquidity presentation
- Tax realignment and valuation judgments can create large one-time benefits or charges
- Litigation and compliance contingencies may require provisions or disclosures

---

*Last updated: 2026-08-11T04:03:56.228997+00:00*